Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Human metapneumovirus in patients hospitalized with acute respiratory infections: A meta-analysis journalArticle 2016 Lefebvre, A.; Manoha, C.; Bour, J. B.; Abbas, R.; Fournel, I.; Tiv, M.; Pothier, P.; Astruc, K.; Aho-Glele, L. S.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis journalArticle 2015 Blanchard, P.; Lee, A.; Marguet, S.; Leclercq, J.; Ng, W. T.; Ma, J.; Chan, A. T.; Huang, P. Y.; Benhamou, E.; Zhu, G.; Chua, D. T.; Chen, Y.; Mai, H. Q.; Kwong, D. L.; Cheah, S. L.; Moon, J.; Tung, Y.; Chi, K. H.; Fountzilas, G.; Zhang, L.; Hui, E. P.; Lu, T. X.; Bourhis, J.; Pignon, J. P.; Group, Mac-Npc Collaborative
Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey journalArticle 2016 Gorphe, P.; Blanchard, P.; Moriniere, S.; Fakhry, N.
Radiation therapy to the primary in metastatic prostate cancer: palliation only or altering tumor biology? journalArticle 2017 Blanchard, P.; Bossi, A.; Fizazi, K.
Dose finding with longitudinal data: simpler models, richer outcomes journalArticle 2015 Paoletti, X.; Doussau, A.; Ezzalfani, M.; Rizzo, E.; Thiebaut, R.
Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block? journalArticle 2016 Ducreux, M.; Pignon, J. P.
Variation in rates of breast cancer surgery: A national analysis based on French Hospital Episode Statistics journalArticle 2016 Rococo, E.; Mazouni, C.; Or, Z.; Mobillion, V.; Koon Sun Pat, M.; Bonastre, J.
Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma journalArticle 2019 Limkin, E. J.; Blanchard, P.
Primary cutaneous and subcutaneous Ewing sarcoma journalArticle 2015 Di Giannatale, A.; Frezza, A. M.; Le Deley, M. C.; Marec-Bérard, P.; Benson, C.; Blay, J. Y.; Bui, B.; Judson, I.; Oberlin, O.; Whelan, J.; Gaspar, N.
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease journalArticle 2018 Danlos, F. X.; Voisin, A. L.; Dyevre, V.; Michot, J. M.; Routier, E.; Taillade, L.; Champiat, S.; Aspeslagh, S.; Haroche, J.; Albiges, L.; Massard, C.; Girard, N.; Dalle, S.; Besse, B.; Laghouati, S.; Soria, J. C.; Mateus, C.; Robert, C.; Lanoy, E.; Marabelle, A.; Lambotte, O.
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial journalArticle 2016 Ribrag, V.; Koscielny, S.; Bosq, J.; Leguay, T.; Casasnovas, O.; Fornecker, L. M.; Recher, C.; Ghesquieres, H.; Morschhauser, F.; Girault, S.; Le Gouill, S.; Ojeda-Uribe, M.; Mariette, C.; Cornillon, J.; Cartron, G.; Verge, V.; Chassagne-Clement, C.; Dombret, H.; Coiffier, B.; Lamy, T.; Tilly, H.; Salles, G.
Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study journalArticle 2018 Aubrun, F.; Zahr, N.; Langeron, O.; Boccheciampe, N.; Cozic, N.; Belin, L.; Hulot, J. S.; Khiami, F.; Riou, B.
Letter on the article "The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?" journalArticle 2017 Hill, C.; Asselain, B.
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference journalArticle 2018 Nicolai, N.; Biasoni, D.; Catanzaro, M. A.; Colecchia, M.; Trama, A.
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma journalArticle 2016 Peeler, C. R.; Mirkovic, D.; Titt, U.; Blanchard, P.; Gunther, J. R.; Mahajan, A.; Mohan, R.; Grosshans, D. R.
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort journalArticle 2018 Kandel, M.; Allayous, C.; Dalle, S.; Mortier, L.; Dalac, S.; Dutriaux, C.; Leccia, M. T.; Guillot, B.; Saiag, P.; Lacour, J. P.; Legoupil, D.; Lesimple, T.; Aubin, F.; Beylot-Barry, M.; Brunet-Possenti, F.; Arnault, J. P.; Granel-Brocard, F.; Stoebner, P. E.; Dupuy, A.; Maubec, E.; Grob, J. J.; Dreno, B.; Rotolo, F.; Ballon, A.; Michiels, S.; Lebbe, C.; Borget, I.
Meta-analysis of prognostic and predictive factors: Towards individual participant data? journalArticle 2018 Faron, Matthieu; Pignon, Jean-Pierre; Paoletti, Xavier
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma journalArticle 2015 Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E.
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy journalArticle 2018 Slimano, F.; Netzer, F.; Borget, I.; Lemare, F.; Besse, B.
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France journalArticle 2015 Scotte, F.; Martelli, N.; Vainchtock, A.; Borget, I.
How individual participant data meta-analyses have influenced trial design, conduct, and analysis journalArticle 2015 Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review journalArticle 2015 Chouaïd, C.; Crequit, P.; Borget, I.; Vergnenegre, A.
Brachytherapy: An overview for clinicians journalArticle 2019 Chargari, C.; Deutsch, E.; Blanchard, P.; Gouy, S.; Martelli, H.; Guerin, F.; Dumas, I.; Bossi, A.; Morice, P.; Viswanathan, A. N.; Haie-Meder, C.
Diagnosis of HPV driven oropharyngeal cancers: Comparing p16 based algorithms with the RNAscope HPV-test journalArticle 2016 Mirghani, H.; Casiraghi, O.; Guerlain, J.; Amen, F.; He, M. X.; Ma, X. J.; Luo, Y.; Mourareau, C.; Drusch, F.; Lakdhar, A. B.; Melkane, A.; St Guily, L.; Badoual, C.; Scoazec, J. Y.; Borget, I.; Auperin, A.; Dalstein, V.; Vielh, P.
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial journalArticle 2018 Arnedos, M.; Bayar, M. A.; Cheaib, B.; Scott, V.; Bouakka, I.; Valent, A.; Adam, J.; Leroux-Kozal, V.; Marty, V.; Rapinat, A.; Mazouni, C.; Sarfati, B.; Bieche, I.; Balleyguier, C.; Gentien, D.; Delaloge, S.; Lacroix-Triki, M.; Michiels, S.; Andre, F.
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials journalArticle 2016 Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I.
Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges journalArticle 2023 Jörg Rahnenführer, Riccardo De Bin, Axel Benner et al.
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial journalArticle 2015 Salgado, R.; Denkert, C.; Campbell, C.; Savas, P.; Nuciforo, P.; Aura, C.; de Azambuja, E.; Eidtmann, H.; Ellis, C. E.; Baselga, J.; Piccart-Gebhart, M. J.; Michiels, S.; Bradbury, I.; Sotiriou, C.; Loi, S.
Innovations for phase I dose-finding designs in pediatric oncology clinical trials journalArticle 2016 Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X.
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer journalArticle 2019 Le Rhun, E.; Wallet, J.; Mailliez, A.; Le Deley, M. C.; Rodrigues, I.; Boulanger, T.; Lorgis, V.; Barriere, J.; Robin, Y. M.; Weller, M.; Bonneterre, J.
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer journalArticle 2016 Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M.
Health state utility and quality of life measures in patients with chronic myeloid leukemia in France journalArticle 2021 Foulon S, Cony-Makhoul P, Guerci-Bresler A, Daban M, Kapso R, Tubert-Bitter P, Bonastre J
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer journalArticle 2018 Criscitiello, C.; Bayar, M. A.; Curigliano, G.; Symmans, F. W.; Desmedt, C.; Bonnefoi, H.; Sinn, B.; Pruneri, G.; Vicier, C.; Pierga, J. Y.; Denkert, C.; Loibl, S.; Sotiriou, C.; Michiels, S.; André, F.
The 5000% case: a glimpse into the financial issue of lung cancer treatment journalArticle 2016 Remon, J.; Bonastre, J.; Besse, B.
Estimating causal effects of time-dependent exposures on a binary endpoint in a high-dimensional setting journalArticle 2018 Asvatourian, V.; Coutzac, C.; Chaput, N.; Robert, C.; Michiels, S.; Lanoy, E.
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials journalArticle 2018 Early Breast Cancer Trialists' Collaborative, Group
Long-term follow-up of TaG1 non-muscle-invasive bladder cancer journalArticle 2015 Olivier Bosset, P.; Neuzillet, Y.; Paoletti, X.; Molinie, V.; Botto, H.; Lebret, T.
Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases journalArticle 2018 Nardin, C.; Mateus, C.; Texier, M.; Lanoy, E.; Hibat-Allah, S.; Ammari, S.; Robert, C.; Dhermain, F.
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role? journalArticle 2016 Ou, D.; Levy, A.; Blanchard, P.; Nguyen, F.; Garberis, I.; Casiraghi, O.; Scoazec, J. Y.; Janot, F.; Temam, S.; Deutsch, E.; Tao, Y.
Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays journalArticle 2018 Jose, V.; Fumagalli, D.; Rothé, F.; Majjaj, S.; Loi, S.; Michiels, S.; Sotiriou, C.